Lonnie Listonsmith

Experienced Health Expert

Health News

1 min read

Women taking the synthetic progestogen cyproterone acetate were at increased risk for brain tumors, a French study found.

The analysis of data on over 250,000 girls and women who filled a prescription for cyproterone acetate showed that these individuals had a six-fold higher risk for developing an intracranial meningiomas compared with women not using the hormone (adjusted hazard ratio 6.6, 95% CI 4.0-11.1), reported Alain Weill, MD, of EPI-PHARE Scientific Interest Group in France, and colleagues in The BMJ.

Cyproterone acetate, a synthetic progestogen with antiandrogen effects, is currently approved in most European countries but not in the U.S.

Read More